Total Debt
$206.5M
Net Debt
-$434.4M
Harmony Biosciences Holdings, Inc. currently has $206.5M in total debt. Net debt is -$434.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
HRMY • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.21 | 0.64 | -0.43Net Cash | 1.27 | 16.2% |
| 2025-12-31 | 0.24 | 0.78 | -0.54Net Cash | 1.27 | 18.8% |
| 2025-09-30 | 0.17 | 0.67 | -0.50Net Cash | 1.21 | 14.0% |
| 2025-06-30 | 0.17 | 0.57 | -0.39Net Cash | 1.11 | 15.6% |
| 2025-03-31 | 0.18 | 0.51 | -0.33Net Cash | 1.06 | 16.8% |
| 2024-12-31 | 0.18 | 0.47 | -0.29Net Cash | 1.00 | 18.2% |
| 2024-09-30 | 0.19 | 0.41 | -0.23Net Cash | 0.93 | 20.0% |
| 2024-06-30 | 0.19 | 0.35 | -0.16Net Cash | 0.86 | 22.0% |
| 2024-03-31 | 0.19 | 0.37 | -0.18Net Cash | 0.85 | 22.8% |
| 2023-12-31 | 0.20 | 0.35 | -0.16Net Cash | 0.81 | 24.2% |
| 2023-09-30 | 0.20 | 0.37 | -0.17Net Cash | 0.78 | 25.7% |
| 2023-06-30 | 0.19 | 0.37 | -0.18Net Cash | 0.76 | 25.5% |
| 2023-03-31 | 0.19 | 0.34 | -0.15Net Cash | 0.72 | 26.8% |
| 2022-12-31 | 0.19 | 0.32 | -0.13Net Cash | 0.67 | 28.4% |
| 2022-09-30 | 0.19 | 0.31 | -0.12Net Cash | 0.64 | 29.8% |
| 2022-06-30 | 0.19 | 0.25 | -0.06Net Cash | 0.51 | 38.0% |
| 2022-03-31 | 0.19 | 0.22 | -0.03Net Cash | 0.46 | 41.4% |
| 2021-12-31 | 0.20 | 0.23 | -0.04Net Cash | 0.43 | 45.2% |
| 2021-09-30 | 0.19 | 0.19 | 0.00 | 0.39 | 49.1% |
| 2021-06-30 | 0.20 | 0.16 | 0.04 | 0.36 | 54.4% |
| 2021-03-31 | 0.19 | 0.14 | 0.05 | 0.34 | 57.8% |
| 2020-12-31 | 0.19 | 0.23 | -0.03Net Cash | 0.43 | 45.5% |
| 2020-09-30 | 0.19 | 0.22 | -0.03Net Cash | 0.32 | 60.3% |
| 2020-06-30 | 0.19 | 0.08 | 0.12 | 0.17 | 114.0% |
| 2020-03-31 | 0.19 | 0.07 | 0.12 | 0.16 | 117.8% |
| 2019-12-31 | 0.10 | 0.02 | 0.07 | 0.11 | 91.8% |
| 2019-03-31 | 0.00 | 0.08 | -0.08Net Cash | 0.00 | — |